CRIS Current Research Information System

BARBARA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.871
AS - Asia 18.832
EU - Europa 15.886
SA - Sud America 1.129
AF - Africa 1.106
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 56.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.527
IT - Italia 5.823
CN - Cina 4.910
SG - Singapore 4.779
VN - Vietnam 4.662
GB - Regno Unito 2.841
DE - Germania 1.643
HK - Hong Kong 1.477
SE - Svezia 997
FR - Francia 830
IN - India 823
BR - Brasile 806
UA - Ucraina 681
RU - Federazione Russa 626
KR - Corea 510
NL - Olanda 475
BD - Bangladesh 474
IE - Irlanda 441
FI - Finlandia 420
JP - Giappone 326
ZA - Sudafrica 273
CH - Svizzera 267
CI - Costa d'Avorio 255
EE - Estonia 181
CA - Canada 164
TG - Togo 158
NG - Nigeria 153
PH - Filippine 129
AR - Argentina 128
JO - Giordania 113
SC - Seychelles 113
AT - Austria 112
ID - Indonesia 104
TH - Thailandia 97
MX - Messico 91
BG - Bulgaria 86
BE - Belgio 81
PL - Polonia 76
ES - Italia 72
TR - Turchia 62
EC - Ecuador 58
TW - Taiwan 54
IQ - Iraq 50
PK - Pakistan 48
AU - Australia 45
CO - Colombia 43
GR - Grecia 43
IR - Iran 40
MA - Marocco 34
CL - Cile 32
UZ - Uzbekistan 29
CD - Congo 28
SA - Arabia Saudita 28
RO - Romania 26
HR - Croazia 24
PT - Portogallo 24
PY - Paraguay 24
MY - Malesia 23
CZ - Repubblica Ceca 21
EG - Egitto 19
AL - Albania 18
TN - Tunisia 16
JM - Giamaica 14
LT - Lituania 14
DZ - Algeria 12
LB - Libano 12
VE - Venezuela 12
GT - Guatemala 11
CR - Costa Rica 10
ET - Etiopia 10
HN - Honduras 10
NZ - Nuova Zelanda 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
KE - Kenya 9
SK - Slovacchia (Repubblica Slovacca) 9
DO - Repubblica Dominicana 8
IL - Israele 8
KZ - Kazakistan 8
PE - Perù 8
BO - Bolivia 7
BY - Bielorussia 7
HU - Ungheria 7
NP - Nepal 7
DK - Danimarca 6
KG - Kirghizistan 6
NI - Nicaragua 6
OM - Oman 6
SM - San Marino 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
AM - Armenia 5
KH - Cambogia 5
LV - Lettonia 5
NO - Norvegia 5
GA - Gabon 4
GH - Ghana 4
KW - Kuwait 4
MT - Malta 4
Totale 56.812
Salva come PNG Salva come JPEG
Città #
Singapore 3.258
Southend 2.422
Houston 2.145
Ashburn 1.805
Fairfield 1.471
Hong Kong 1.369
San Jose 1.163
Hefei 1.078
Ho Chi Minh City 1.026
Hanoi 902
Chandler 843
Santa Clara 725
Bologna 715
Dong Ket 680
Woodbridge 675
Wilmington 633
Seattle 623
Beijing 592
Milan 570
Princeton 526
Cambridge 472
Ann Arbor 471
Rome 465
Seoul 454
Boardman 440
Dublin 433
Jacksonville 388
New York 376
Los Angeles 362
Council Bluffs 356
Helsinki 323
Lauterbourg 323
Munich 279
Tokyo 271
Abidjan 255
Dallas 244
Padova 237
Nanjing 232
Westminster 219
Bern 207
Florence 186
Buffalo 181
Berlin 166
Lomé 158
Da Nang 149
Frankfurt am Main 147
Naples 146
Haiphong 145
Jinan 130
Turin 125
Bengaluru 117
Guangzhou 117
Shanghai 114
Amman 110
Abeokuta 109
San Diego 108
Shenyang 103
Saint Petersburg 100
São Paulo 98
Redondo Beach 97
Brescia 91
Changsha 88
Orem 86
Johannesburg 81
Sofia 81
Bremen 78
Tianjin 78
Mülheim 77
Vienna 72
Medford 71
Chicago 65
Dearborn 64
Hebei 64
Nanchang 62
Palermo 61
Phoenix 61
Falls Church 59
Amsterdam 58
Parma 57
Verona 55
Hyderabad 54
Hải Dương 53
Toronto 52
Zhengzhou 52
Des Moines 51
Washington 50
Atlanta 48
Brussels 48
London 48
Hangzhou 47
Jakarta 47
Lappeenranta 47
San Francisco 47
Yubileyny 46
Falkenstein 45
Nuremberg 45
Rimini 45
Jiaxing 44
Montreal 44
Bari 43
Totale 34.999
Salva come PNG Salva come JPEG
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.817
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 1.601
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 790
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. 556
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 410
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 359
La sindrome dell'intestino irritabile. 350
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 329
Randomised controlled trial of mesalazine in IBS 325
Management of Irritable Bowel Syndrome With Diarrhea 316
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 314
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 314
Chronic intestinal pseudo-obstruction related to viral infections. 304
Il sistema nervoso enterico. 302
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. 278
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 277
Use of macrogol 4000 in chronic constipation. 276
[Some practical questions on chronic stipsis treatment with prucalopride] 272
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 259
Sigmoid compliance and visceral perception in spinal cord injury patients 246
Diagnosis and therapy of irritable bowel syndrome 242
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 241
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 240
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 240
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 238
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 238
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 237
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 236
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 232
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. 231
A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. 231
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 230
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics 227
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 227
New insights into human enteric neuropathies. 222
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 221
X Congresso Nazionale delle Malattie Digestive AIGO-SIED-SIGE. 220
Chemosensitività intestinale, nervi, cellule enteroendocrine, recettori del gusto 219
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 219
CLINICAL AND NEUROCHEMICAL FEATURES OF CHRONIC CONSTIPATION IN PATIENTS WITH PARKINSON DISEASE 218
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 216
The immune system in irritable bowel syndrome. 216
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 215
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 214
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 212
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 211
Chronic intestinal pseudo-obstruction. 210
International consensus statement on microbiome testing in clinical practice 207
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 206
MALATTIA DA REFLUSSO GASTROESOFAGEO 205
Mutations in RAD21 Disrupt Regulation of APOB in Patients With Chronic Intestinal Pseudo-Obstruction. 204
Neuropathological analisys and clinical correlates of chronic constipation in patients with parkinson’s disease 202
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. 199
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 198
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 198
H 2breath testing for other gas-related syndromes 197
A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome 196
Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome 194
Expression and regulation of α-transducin in the pig gastrointestinal tract 193
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 192
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 192
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 191
Diagnostic challenges of symptomatic uncomplicated diverticular disease 191
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 190
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 190
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. 189
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression 188
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 188
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 187
A new reliable method for evaluating gallbladder dynamics the 3-dimensional sonographic examination 186
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 185
Paraneoplastic Syndrome 185
Gut microbiota and related diseases: clinical features. 185
Pancreatic involvement in systemic sarcoidosis. A case report. 184
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 184
Glioplasticity in irritable bowel syndrome 184
A mediator cocktail released from mucosal biopsies of IBS patients excites human and guinea pig enteric neurons. 183
Caratterizzazione genetico-molecolare e morfologica di un modello sperimentale di megacolon congenito non agangliare. 183
Evidence of RET/GDNF-related apolipoprotein B (APOB) activation and altered expression in patients with chronic intestinal pseudo-obstruction (CIPO) 183
Changes of α-transducin immunoreactivity (IR) in the pig gastrointestinal (GI) mucosa evoked by fasting/refeeding. 183
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 183
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 182
Post COVID-19 irritable bowel syndrome 181
Expression of alpha-transducin, a chemoreceptive molecule, in endocrine and non-endocrine cells of the pig gastrointestinal tract 181
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 181
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 181
Post-infectious Irritable Bowel Syndrome. 180
null 179
Gastroesophageal reflux disease: therapeutic features (Part II)] 178
Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome 178
Neuroplasticità gastroenterica: dai geni all’infiammazione. 177
Sensorineural hearing loss and celiac disease: a coincidental finding 176
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 176
Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. 176
Gastro-oesophageal reflux and interstitial lung disease. 175
Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome 174
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 173
Enteric neuroplasticity evoked by inflammation 172
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. 171
Clinical approach to diarrhea 171
Totale 25.665
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.109 0 0 0 0 0 0 0 0 0 0 0 1.109
2021/20225.375 526 174 269 250 400 276 141 297 189 243 1.840 770
2022/20235.221 498 718 318 601 338 352 173 373 881 197 386 386
2023/20242.583 136 280 190 198 265 492 143 160 104 231 198 186
2024/20258.941 408 1.095 805 655 1.282 529 759 462 333 513 628 1.472
2025/202622.217 1.578 2.145 1.953 1.638 1.974 1.085 2.604 869 4.080 1.650 1.303 1.338
Totale 57.858